Addison’s Disease Drugs Market to Grow at 10.6% CAGR | Size, Share, and Trends by 2031
The Addison’s Disease Drugs Market has gained considerable momentum as awareness of adrenal insufficiency grows and pharmaceutical advancements expand treatment options. Addison’s disease, a rare endocrine disorder caused by insufficient production of hormones like cortisol and aldosterone by the adrenal glands, requires lifelong medication to manage symptoms and prevent...
0 Σχόλια
0 Μοιράστηκε